US Broker Ratings

Galapagos NV (GLPG) Stock Analysis: Navigating the Upside Amidst Biotech Volatility

Galapagos NV (GLPG), a pioneering biotech company headquartered in Mechelen, Belgium, is capturing the attention of the healthcare investment community with its innovative approach to developing treatments for oncology and..

Novavax, Inc. (NVAX) Stock Analysis: Exploring a 33.84% Potential Upside in the Biotechnology Sector

Investors are keeping a watchful eye on Novavax, Inc. (NVAX), a notable player in the biotechnology sector with a market capitalization of $1.56 billion. The company’s innovative approach to vaccine..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Exploring a 24.76% Potential Upside

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a biopharmaceutical firm specializing in treatments for central nervous system (CNS) diseases, has captured investor attention with its promising market position and growth potential. With..

Omnicell, Inc. (OMCL) Stock Analysis: Unpacking a 9.3% Potential Upside in Healthcare Innovation

Omnicell, Inc. (NASDAQ: OMCL) is a key player in the healthcare sector, particularly in the niche of health information services. Known for its advanced medication management solutions and adherence tools,..

Disc Medicine, Inc. (IRON) Stock Analysis: Biotech Innovator with a 57% Upside Potential

Disc Medicine, Inc. (NASDAQ: IRON), a pioneering entity in the biotechnology sector, is drawing significant attention from investors due to its promising portfolio and strong analyst ratings. With a market..

GRAIL, Inc. (GRAL) Stock Analysis: Navigating a 26.3% Revenue Growth in the Healthcare Sector

Investors with an eye on the healthcare sector might find GRAIL, Inc. (NASDAQ: GRAL) a compelling story, thanks to its significant 26.3% revenue growth and innovative approach in the diagnostics..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Navigating Growth with a 6.12% Potential Upside

For investors exploring opportunities within the healthcare sector, Amneal Pharmaceuticals, Inc. (NYSE: AMRX) presents an intriguing prospect. With a market capitalization of $4.27 billion, Amneal operates as a diversified global..

Neogen Corporation (NEOG) Stock Analysis: A Diagnostic Innovator with 16.55% Potential Upside

Neogen Corporation (NEOG), a key player in the healthcare sector focusing on diagnostics and research, has garnered attention from investors due to its notable potential upside of 16.55%, as indicated..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Unveiling a 44.95% Potential Upside for Investors

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands at an intriguing junction for investors with its robust portfolio in non-opioid pain management solutions. Specializing in the healthcare sector, particularly within the drug..

Schrodinger, Inc. (SDGR) Investor Outlook: Unveiling a 60.98% Potential Upside with Strong Buy Ratings

Schrodinger, Inc. (NASDAQ: SDGR) stands as a compelling player in the healthcare sector, specifically within the health information services industry. With its market capitalization hovering around $1.14 billion, Schrodinger is..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: 167% Potential Upside Sparks Investor Interest

Investors with a keen eye on the biotechnology sector should consider ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a promising player in the healthcare industry. With its headquarters in San Diego, California,..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A Promising Biotech Play with 20.63% Potential Upside

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is a burgeoning player in the biotechnology space, focusing on innovative treatments for dermatological diseases. Headquartered in Westlake Village, California, Arcutis is making waves with..

Premier, Inc. (PINC) Stock Analysis: Navigating Healthcare with a 2.97% Dividend Yield

Premier, Inc. (NASDAQ: PINC) stands as a notable entity within the healthcare sector, particularly in the realm of Health Information Services. With a market capitalization of $2.34 billion, Premier, Inc...

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Unveiling a 49.24% Upside in Biotech

Apogee Therapeutics, Inc. (NASDAQ: APGE), a burgeoning name in the biotechnology sector, is attracting significant investor attention with its promising clinical-stage developments and substantial upside potential. With a market capitalization..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Evaluating a 27.3% Potential Upside in Healthcare Innovation

Tandem Diabetes Care, Inc. (TNDM) stands at the forefront of medical device innovation, specializing in cutting-edge technology solutions for diabetes management. With a market capitalization of $1.37 billion, Tandem Diabetes..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Exploring a 29% Potential Upside in Biotech Innovation

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a noteworthy player in the biotechnology sector, has been turning investors’ heads with a market capitalization of $2.88 billion and a promising pipeline of innovative..

GeneDx Holdings Corp. (WGS) Investor Outlook: A Promising 62% Upside Potential in the Genomics Sector

GeneDx Holdings Corp. (NASDAQ: WGS) stands as a notable player in the healthcare sector, particularly within the diagnostics and research industry. Headquartered in Stamford, Connecticut, this genomics company specializes in..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Exploring a 20.35% Upside Potential

Structure Therapeutics Inc. (NASDAQ: GPCR) is capturing significant attention in the biotechnology sector with its robust portfolio of novel oral small molecule therapeutics aimed at addressing chronic diseases with unmet..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Exploring a Potential 41.75% Upside

Dynavax Technologies Corporation (NASDAQ: DVAX) is a prominent player in the biotechnology sector, specifically within the specialty and generic drug manufacturing industry. With its headquarters in Emeryville, California, Dynavax focuses..

Astrana Health Inc. (ASTH) Investor Outlook: Unpacking the 35.52% Upside Potential

Astrana Health Inc. (NASDAQ: ASTH), a healthcare management company, has been a subject of interest for investors seeking exposure in the healthcare sector. With its market capitalization standing at $1.37..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds